Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ARWR [NASD]
Arrowhead Research Corp.
Index- P/E- EPS (ttm)-1.27 Insider Own1.10% Shs Outstand45.32M Perf Week-19.53%
Market Cap578.74M Forward P/E- EPS next Y-0.52 Insider Trans- Shs Float44.85M Perf Month-45.71%
Income-37.20M PEG- EPS next Q-0.20 Inst Own69.50% Short Float7.35% Perf Quarter0.87%
Sales0.20M P/S2893.68 EPS this Y31.60% Inst Trans24.46% Short Ratio1.64 Perf Half Y57.46%
Book/sh2.19 P/B5.83 EPS next Y39.50% ROA-80.70% Target Price28.75 Perf Year609.44%
Cash/sh1.67 P/C7.66 EPS next 5Y14.44% ROE-98.60% 52W Range1.65 - 27.63 Perf YTD17.70%
Dividend- P/FCF- EPS past 5Y28.30% ROI-82.60% 52W High-53.78% Beta2.60
Dividend %- Quick Ratio8.50 Sales past 5Y-25.40% Gross Margin- 52W Low673.94% ATR1.91
Employees54 Current Ratio8.50 Sales Q/Q-72.50% Oper. Margin- RSI (14)34.58 Volatility16.88% 13.29%
OptionableYes Debt/Eq0.03 EPS Q/Q15.20% Profit Margin- Rel Volume1.41 Prev Close12.39
ShortableYes LT Debt/Eq0.01 EarningsMay 06 AMC Payout- Avg Volume2.01M Price12.77
Recom2.00 SMA20-22.32% SMA50-34.24% SMA20026.94% Volume2,834,021 Change3.07%
05-Mar-14Initiated RBC Capital Mkts Outperform $35
05-Mar-14Initiated Deutsche Bank Buy $45
26-Feb-13Initiated Dawson James Buy $4
16-Apr-14 09:47AM  Trade-Ideas: Arrowhead Research Corporation (ARWR) Is Today's "Dead Cat Bounce" Stock at TheStreet +8.49%
14-Apr-14 03:00PM  Why Arrowhead Research (ARWR) Stock is Down Today at TheStreet
02:42PM  Alnylam slips after Novartis reportedly cuts back RNAi development at theflyonthewall.com
07-Apr-14 10:15AM  Trade-Ideas: Arrowhead Research Corporation (ARWR) Is Today's "Dead Cat Bounce" Stock at TheStreet
01-Apr-14 01:37PM  Why Arrowhead Research Corp. Shares Jumped at Motley Fool +11.33%
11:24AM  Why Arrowhead Research (ARWR) Stock Is Up Today at TheStreet
07:31AM  Arrowhead completes enrollment of first cohort in phase 2a trial of ARC-520 at theflyonthewall.com
07:30AM  Arrowhead Completes Enrollment of First Cohort in Phase 2a Trial of Chronic Hepatitis B Candidate ARC-520 Business Wire
26-Mar-14 06:31PM  3 Biotechs Falling Like a Knife: Arrowhead, Celldex, Receptos at Motley Fool
24-Mar-14 12:07PM  On The Fly: Midday Wrap at theflyonthewall.com -16.09%
07:30AM  Arrowhead Begins Dosing in Phase 2a Trial of RNAi Therapeutic ARC-520 in Chronic Hepatitis B Patients Business Wire
21-Mar-14 06:03PM  Nasdaq stocks posting largest percentage decreases AP -13.06%
01:24PM  Nasdaq stocks posting largest percentage decreases AP
15-Mar-14 09:32AM  It's Official: Merck Now Owns Part of Alnylam at Motley Fool
14-Mar-14 01:21PM  Nasdaq stocks posting largest percentage decreases AP
13-Mar-14 06:05PM  Nasdaq stocks posting largest percentage decreases AP -8.35%
01:59PM  Nasdaq stocks posting largest percentage decreases AP
10-Mar-14 07:30AM  Arrowhead to Present at Barclays Global Healthcare Conference Business Wire +7.66%
07:30AM  Arrowhead to Present at Barclays Global Healthcare Conference
07-Mar-14 02:31PM  Arrowhead Research Surges as It Advances Its Drug for Hepatitis B into Phase 2 at Motley Fool
05-Mar-14 04:22PM  On The Fly: Closing Wrap at theflyonthewall.com +24.46%
02:49PM  3 Biotech Winners on Wednesday: Arrowhead, Osiris, Tekmira at Wall St. Cheat Sheet
02:49PM  3 Biotech Winners on Wednesday: Arrowhead, Osiris, Tekmira
02:31PM  Why Arrowhead Research (ARWR) His a Five-Year High Today at TheStreet
02:31PM  Why Arrowhead Research (ARWR) His a Five-Year High Today
12:41PM  On The Fly: Midday Wrap at theflyonthewall.com
12:02PM  Today's Top Performers In Health Care at TheStreet
12:02PM  Today's Top Performers In Health Care
11:50AM  Arrowhead Research: 'Early Innings' for 'Major Story' at Barrons.com
11:50AM  Arrowhead Research: 'Early Innings' for 'Major Story'
11:14AM  Arrowhead Surges As Analysts Laud Hepatitis B Drug Optionetics
11:14AM  Arrowhead Surges As Analysts Laud Hepatitis B Drug at Investor's Business Daily
11:14AM  Arrowhead Surges As Analysts Laud Hepatitis B Drug
06:17AM  Coverage initiated on Arrowhead Research by RBC Capital Mkts Briefing.com
06:17AM  Coverage initiated on Arrowhead Research by RBC Capital Mkts and Deutsche Bank Briefing.com
03-Mar-14 09:45AM  Arrowhead Research Corporation (ARWR) Marked As A Dead Cat Bounce Stock at TheStreet
09:45AM  Arrowhead Research Corporation (ARWR) Marked As A Dead Cat Bounce Stock
07:30AM  Arrowhead Receives Regulatory Approval to Begin Phase 2a Trial of Chronic Hepatitis B Candidate ARC-520 Business Wire
24-Feb-14 11:54AM  Use Options For A Chance To Buy ARWR At A 55% Discount at TheStreet
08:59AM  Arrowhead Closes Underwritten Offering with Gross Proceeds of $120 Million Business Wire
21-Feb-14 04:08PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhi EDGAR Online
07:30AM  Arrowhead Listing Upgraded to NASDAQ Global Select Market Business Wire
20-Feb-14 04:01PM  Arrowhead to Present at RBC Capital Markets' Global Healthcare Conference Business Wire
19-Feb-14 09:14AM  Arrowhead: A Functional Cure For The Hepatitis B Virus at Seeking Alpha +11.29%
09:05AM  Arrowhead Announces Pricing of Underwritten Offering of Common Stock Business Wire
18-Feb-14 04:15PM  Arrowhead Research files to sell common stock, no amount given theflyonthewall.com
04:14PM  Arrowhead Announces Proposed Underwritten Offering of Common Stock Business Wire
12-Feb-14 04:09PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib EDGAR Online
08-Feb-14 01:04PM  ARROWHEAD RESEARCH CORP Financials EDGAR Online Financials
07-Feb-14 08:51AM  Arrowhead: There Is Still Plenty Of Room For Share Price Appreciation at Seeking Alpha +18.64%
07:31AM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vot EDGAR Online
06-Feb-14 11:59AM  Arrowhead Research Continues Its Surge After Analyst Upgrade at Wall St. Cheat Sheet
05-Feb-14 05:12AM  Arrowhead Research price target raised to $20 from $12 at Piper Jaffray at theflyonthewall.com
04-Feb-14 07:32PM  Arrowhead's CEO Discusses F1Q 2014 Results - Earnings Call Transcript at Seeking Alpha
04:40PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
04:33PM  ARROWHEAD RESEARCH CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
04:05PM  Arrowhead Reports Fiscal 2014 First Quarter Financial Results Business Wire
07:30AM  Arrowhead to Participate in Panel Discussions at 16th Annual BIO CEO & Investor Conference Business Wire
28-Jan-14 04:10PM  Arrowhead to Report Fiscal 2014 First Quarter Financial Results Business Wire +13.55%
04:10PM  Arrowhead to Report Fiscal 2014 First Quarter Financial Results
27-Jan-14 02:14PM  Arrowhead Research - Ground-Floor Opportunity Or Biotech Bubble Baby? at Seeking Alpha
02:14PM  Arrowhead Research - Ground-Floor Opportunity Or Biotech Bubble Baby?
13-Jan-14 01:20PM  3 Biotechs Generating a Lot Of Buzz at Wall St. Cheat Sheet
01:20PM  3 Biotechs Generating a Lot Of Buzz
08-Jan-14 11:38AM  Arrowhead Research's Nanotherapy Bet at Motley Fool +6.59%
11:38AM  Arrowhead Research's Nanotherapy Bet
24-Dec-13 01:04PM  ARROWHEAD RESEARCH CORP Financials EDGAR Online Financials
01:04PM  ARROWHEAD RESEARCH CORP Financials
19-Dec-13 04:32PM  3 Stocks Near 52-Week Highs Worth Selling at Motley Fool
04:32PM  3 Stocks Near 52-Week Highs Worth Selling
18-Dec-13 11:17PM  Arrowhead Research's CEO Discusses F4Q2013 Results - Earnings Call Transcript at Seeking Alpha
11:17PM  Arrowhead Research's CEO Discusses F4Q 2013 Results - Earnings Call Transcript at Seeking Alpha
11:17PM  Arrowhead Research's CEO Discusses F4Q 2013 Results - Earnings Call Transcript
04:17PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
04:17PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
04:05PM  Arrowhead Reports Fiscal 2013 Fourth Quarter and Year-End Financial Results Business Wire
04:05PM  Arrowhead Reports Fiscal 2013 Fourth Quarter and Year-End Financial Results
04:03PM  ARROWHEAD RESEARCH CORP Files SEC form 10-K, Annual Report EDGAR Online
04:03PM  ARROWHEAD RESEARCH CORP Files SEC form 10-K, Annual Report
11-Dec-13 04:10PM  Arrowhead to Report Fiscal 2013 Fourth Quarter and Year-End Financial Results Business Wire
04:10PM  Arrowhead to Report Fiscal 2013 Fourth Quarter and Year-End Financial Results
09-Dec-13 04:02PM  Arrowhead Presents Phase 1 Data on ARC-520 at HepDART 2013 Business Wire
04:02PM  Arrowhead Presents Phase 1 Data on ARC-520 at HepDART 2013
04-Dec-13 02:45AM  Arrowhead Research Corp: What Am I Missing? at Seeking Alpha
02:45AM  Arrowhead Research Corp: What Am I Missing?
27-Nov-13 02:20PM  A Hedge Fund is Buying Shares in These 2 Biotech Stocks at Wall St. Cheat Sheet
26-Nov-13 07:30AM  Arrowhead to Present at Piper Jaffray Healthcare Conference Business Wire
25-Nov-13 07:31AM  InPlay: Arrowhead Research submits application to begin Phase 2a trial of ARC-520 for the treatment of chronic hepatitis B infection Briefing.com
07:30AM  Arrowhead Submits Application to Begin Phase 2a Trial of ARC-520 for the Treatment of Chronic Hepatitis B Infection Business Wire
07-Nov-13 07:30AM  Arrowhead to Present at Upcoming Conferences Business Wire
04-Nov-13 07:31AM  InPlay: Arrowhead Research presents data suggesting ARC-520 induces therapeutic flare in Chronic Hepatitis B; presentation demonstrates reduction of key HBV antigens and DNA, and evidence of immune reactivation in a chimpanzee with chronic Briefing.com
07:30AM  Arrowhead Presents Data Suggesting ARC-520 Induces Therapeutic Flare in Chronic Hepatitis B Business Wire
25-Oct-13 08:06PM  Arrowhead Announces Inducement Grants Under NASDAQ Rule 5635(c)(4) Business Wire
22-Oct-13 06:03PM  Nasdaq stocks posting largest percentage decreases AP -9.72%
01:17PM  Nasdaq stocks posting largest percentage decreases AP
18-Oct-13 07:30AM  Arrowhead to Present at Upcoming Conferences Business Wire
14-Oct-13 09:53AM  Rxi Pharmaceuticals Is Undervalued In The RNAi Sector at Seeking Alpha
07:30AM  Arrowhead Closes Private Offering with Net Proceeds of $60 Million Business Wire
10-Oct-13 11:50AM  Long And Short Plays For A Whipsaw Stock Market at Forbes +10.79%
09:44AM  ARWR: On Track To Advance ARC-520 For HBV at Seeking Alpha
Arrowhead Research Corporation, a biopharmaceutical company, develops targeted RNAi therapeutics in the United States. The company's product candidate comprise ARC-520, an RNAi-based therapeutic that has completed a Phase 1 clinical trial for the treatment of chronic hepatitis B virus (HBV) infection; and Adipotide, which is in Phase I clinical trial for the treatment for obesity and related metabolic disorders. Its platform technologies include Dynamic Polyconjugate platform, a RNA delivery system that addresses multiple organ systems and cell types, promotes multi-log gene knockdown, and induces endosomal escape; and Homing Peptides platform, a library of short peptides. The company also develops DPC-enabled RNAi therapeutic, a pre-clinical stage product to treat an undisclosed orphan liver disease. It also has research collaboration and license agreement with Shire AG to develop and commercialize targeted peptide-drug conjugates. The company, formerly known as InterActive Group, Inc., was founded in 2003 and is headquartered in Pasadena, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Myszkowski Kenneth AllenCFOFeb 12Option Exercise2.0116,00032,16087,500Feb 12 07:15 PM
Myszkowski Kenneth AllenCFOFeb 12Sale18.7716,000300,29071,500Feb 12 07:15 PM
FRYKMAN EDWARD WDirectorFeb 07Option Exercise10.005,00050,00027,000Feb 10 07:45 PM
FRYKMAN EDWARD WDirectorFeb 07Sale15.983,14850,29623,852Feb 10 07:45 PM